Showing results (271-280 of 453) with videos related to

Sort By:
Pageof 46
Plos One|February 18, 2010
Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collectionsEnrico Domenici, David R Willé, Federica Tozzi, et al.
JAMA Psychiatry|August 28, 2014
Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer diseaseRonald Lautner, Sebastian Palmqvist, Niklas Mattsson, et al.
Journal of Psychiatric Research|July 23, 2013
CNTNAP2 polymorphisms and structural brain connectivity: a diffusion-tensor imaging studyChristian Clemm von Hohenberg, Marlene C Wigand, Marek Kubicki, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 14, 2017
Cognitive Characterization of Schizophrenia Risk Variants Involved in Synaptic Transmission: Evidence of CACNA1C's Role in Working MemoryDonna Cosgrove, Omar Mothersill, Kimberley Kendall, et al.
The International Journal of Neuropsychopharmacology|November 10, 2024
Anhedonia is associated with a specific depression profile and poor antidepressant responseAntonina Luca, Maria Luca, Siegfried Kasper, et al.
Human Molecular Genetics|November 16, 2007
Strong evidence that GNB1L is associated with schizophreniaNigel M Williams, Beate Glaser, Nadine Norton, et al.
Biological Psychiatry|February 4, 2021
Relationship Between Serum NMDA Receptor Antibodies and Response to Antipsychotic Treatment in First-Episode PsychosisThomas A Pollak, Angela Vincent, Conrad Iyegbe, et al.
Archives of General Psychiatry|October 6, 2010
Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controlsKristin K Nicodemus, Amanda J Law, Eugenia Radulescu, et al.
Pageof 46